Social Communication of Maternal Immune Activation-Affected Offspring Is Improved by Si-Based Hydrogen-Producing...

Area of Science:

• Neuroscience
• Immunology
• Materials Science

Background:

• Maternal immune activation (MIA) during pregnancy increases offspring risk for neurodevelopmental disorders, including autism spectrum disorder (ASD) and schizophrenia.
• Cytokines from MIA cross the placenta, impacting fetal brain development and increasing vulnerability.
• Existing therapeutic strategies for MIA-related risks are limited.

Purpose of the Study:

• To investigate the potential of a novel silicon (Si)-based hydrogen-producing antioxidant agent as a prophylactic therapy against MIA.
• To evaluate the therapeutic effects of the Si-based agent on the neurodevelopmental outcomes and brain inflammation in offspring exposed to MIA.

Main Methods:

• Development of a Si-based agent designed for continuous hydrogen production in vivo.
• Utilized a mouse model of MIA to simulate pregnancy complications.
• Administered the Si-based agent to pregnant mice and assessed offspring for behavioral changes and gene expression in the brain.

Main Results:

• The Si-based agent significantly improved social communication deficits in MIA offspring mice.
• Treatment with the Si-based agent suppressed the expression of key inflammation-associated genes (Ifna1 and Il-6) in the brains of MIA offspring.
• The Si-based agent demonstrated continuous and effective hydrogen production within the body.

Conclusions:

• The Si-based agent is a promising prophylactic agent against MIA-induced developmental risks.
• This agent may serve as a novel therapeutic or preventative strategy for ASD and other child health conditions associated with MIA.
• The antioxidative and anti-inflammatory properties of medical hydrogen, delivered via the Si-based agent, are key to its therapeutic efficacy.